Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM. Read more about Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM.
Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas. Read more about Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas.
New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163. Read more about New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163.
Convection-enhanced delivery of nanoliposomal CPT-11 (irinotecan) and PEGylated liposomal doxorubicin (Doxil) in rodent intracranial brain tumor xenografts. Read more about Convection-enhanced delivery of nanoliposomal CPT-11 (irinotecan) and PEGylated liposomal doxorubicin (Doxil) in rodent intracranial brain tumor xenografts.
Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Read more about Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype.
Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma. Read more about Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma.
In vivo efficacy of a novel histone deacetylase inhibitor in combination with radiation for the treatment of gliomas. Read more about In vivo efficacy of a novel histone deacetylase inhibitor in combination with radiation for the treatment of gliomas.
Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report. Read more about Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report.
Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts. Read more about Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts.
Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model. Read more about Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model.
